Europe — EMA
Leukeran
GNH USA supplies Leukeran (Chlorambucil), a alkylating antineoplastic agent for chronic lymphocytic leukemia, Hodgkin's and non‑Hodgkin lymphoma.
Request sourcing
What is Chlorambucil?
Chlorambucil, the active ingredient in Leukeran, is an alkylating agent presented as a oral tablet for oral use. It treats certain lymphoid malignancies such as chronic lymphocytic leukemia, Hodgkin's lymphoma and other related cancers.
GNH USA supplies Leukeran as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Chlorambucil used for?
Leukeran is an alkylating chemotherapy agent used in a range of lymphoid malignancies.
Chronic lymphocytic leukemia: reduces malignant lymphocyte count and slows disease progression. Hodgkin's lymphoma: contributes to remission and disease control. Non‑Hodgkin lymphoma: provides cytoreduction in indolent forms. Chronic myelogenous leukemia: used as part of therapy for disease management. Other lymphoid malignancies: offers antineoplastic activity in selected cases.
What are the side effects of Chlorambucil?
Leukeran may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Nausea and vomiting: gastrointestinal upset occurring shortly after dosing. - Myelosuppression: decreased white blood cells, red cells, and platelets. - Alopecia: temporary hair thinning or loss. - Fatigue: generalized tiredness during treatment. - Mild skin rash: localized erythema or itching.
Serious or Rare Side Effects: - Severe neutropenia: heightened infection risk requiring immediate medical attention. - Hemorrhagic cystitis: bladder irritation that may cause blood in urine. - Secondary malignancies: rare development of new cancers after prolonged exposure.
What precautions apply to Chlorambucil?
Before initiating Leukeran, several safety considerations should be observed.
Dose adjustment: consider renal or hepatic impairment. Blood monitoring: regular CBC required to detect myelosuppression. Infection risk: monitor for signs of infection due to neutropenia. Pregnancy: avoid use unless benefits outweigh risks. Drug interactions: review concomitant medications for CYP2D6 substrates. Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.
What does Chlorambucil interact with?
Leukeran can interact with other medicines, influencing efficacy or safety.
Major Interactions (Avoid): - Live vaccines: increased risk of infection. - Strong CYP2D6 inhibitors: may increase chlorambucil exposure. - Radiation therapy: additive bone marrow suppression.
Moderate Interactions (Monitor Closely): - Anticoagulants: enhanced bleeding risk. - Allopurinol: may increase hematologic toxicity. - Azathioprine: additive immunosuppression.
Frequently asked questions
What is Leukeran used for?+
How does chlorambucil work?+
What is the usual dose of Leukeran?+
Is Leukeran safe during pregnancy or breastfeeding?+
How do I order Leukeran from GNH USA?+
How does Leukeran compare with the main alternative drug or class?+
How should Leukeran be stored and handled?+
How is Leukeran administered?+
What are the most serious risks to watch for while taking Leukeran?+
Who should not use Leukeran?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo